Menu Back to Pharmacovigilance-and-Risk-Management-Strategies-Conference-21002

Featured

Want to learn more about Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!

Continuing Education

Learn more

Highlights & Features

Learn more

Short Course or Primer

To keep you at the forefront.

  • Jan 19, 2021

    Short Course 1: Reference Safety Information

    Learn more

  • Jan 20, 2021

    Short Course 2: Pharmacovigilance and Risk Management Planning

    Learn more

  • Jan 25, 2021

    Short Course 3: Introduction to Statistics in Pharmacovigilance

    Learn more

Program Committee

  • Stephen Knowles, MD, MRCP
    Stephen Knowles, MD, MRCP • Chief Medical Officer
    Halozyme Therapeutics, United States
  • Lesley Wise, PhD, MSc
    Lesley Wise, PhD, MSc • Managing Director
    Wise PV&RM Ltd, United Kingdom
  • Mariette Boerstoel-Streefland, MD, MBA, MS
    Mariette Boerstoel-Streefland, MD, MBA, MS • Senior Vice President Patient Safety, Chief Safety Officer
    AstraZeneca, United States
  • Cheryl Campbell, MS
    Cheryl Campbell, MS • Associate Director of Executive Operations/Outreach and Communications, OSE,CDER
    FDA, United States
  • E. Stewart Geary, MD
    E. Stewart Geary, MD • Senior Vice President
    Eisai Co., Ltd., Japan
  • Lisa Melanie Harinstein, PharmD
    Lisa Melanie Harinstein, PharmD • Team Leader, Division of Pharmacovigilance, FDA
    FDA, United States
  • Jeremy Jokinen, PhD, MS
    Jeremy Jokinen, PhD, MS • Vice President and Head, Global Risk Management and International Patient Safety
    Bristol Myers Squibb, United States
  • Annette Stemhagen, DrPH, PhD, FISPE
    Annette Stemhagen, DrPH, PhD, FISPE • Chief Science Officer
    UBC, United States
  • Sarah Vaughan
    Sarah Vaughan • Head of Vigilance Development
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Annette S. Williams, MBA, RPh
    Annette S. Williams, MBA, RPh • Vice President, Pharmacovigilance
    IQVIA, United States
  • Jo Wyeth, PharmD
    Jo Wyeth, PharmD • Associate Director for Postmarket Assessments, OMEPRM, OSE, CDER
    FDA, United States
  • Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
    Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP • Strategy Consultant
    United Kingdom
  • William Gregory, PhD
    William Gregory, PhD • Senior Director, Safety and Risk Management
    Pfizer Inc, United States
  • Valerie E. Simmons, MD, FFPM
    Valerie E. Simmons, MD, FFPM • Senior Medical Fellow, Global Patient Safety
    Eli Lilly and Company Ltd, United Kingdom
Load More

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download